Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Ylitalo K, Vanttinen T, Halmesmaki E, Tyni T
This is not a stacking recommendation
All adults had a recorded diagnosis of obesity defined as BMI of 30 kg/m 2 or higher or BMI of 27 kg/m 2 to 29.9 kg/m 2 with at least one weight-related comorbidity
Prescription medications directly mimic the GLP-1 hormone
Find the nearest Life Pharmacy where this item is available Overview Wegovy 25mg Tablets are a prescription-only, once-daily oral GLP-1 receptor agonist treatment containing semaglutide, developed by Novo Nordisk to support adults living with obesity or overweight with weight-related health conditions
US$ 22.98
US$ 26.16
US$ 28.11
US$ 24.38
